Labcorp launches blood test to accelerate Alzheimer’s diagnosis

Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.

Related Posts

How Trump’s trade fight could impact the medtech industry

Feb 12, 2025  0

FDA brings back some fired device staff

Feb 24, 2025  0

Solventum cuts 800 positions in restructuring

Mar 26, 2025  0

Comments

Name

Email

Comment

Post Comment